Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T09:51:24.876Z Has data issue: false hasContentIssue false

C-Ret Proto-Oncogene Expression in Human Prostate: An Immunohistochemical Evaluation

Published online by Cambridge University Press:  02 July 2020

D.M. Dawson
Affiliation:
Institute of Pathology, Case Western Reserve University Medical Center, Cleveland, Ohio44106
E. G. Lawrence
Affiliation:
Institute of Pathology, Case Western Reserve University Medical Center, Cleveland, Ohio44106
G. MacLennan
Affiliation:
Institute of Pathology, Case Western Reserve University Medical Center, Cleveland, Ohio44106
T.G. Pretlow
Affiliation:
Institute of Pathology, Case Western Reserve University Medical Center, Cleveland, Ohio44106
Get access

Extract

C-ret proto-oncogene encodes a protein in the tyrosine kinase (TK) family of transmembrane receptors for growth factors. C-ret expression has been identified in normal tissues and tumors of neural crest origin such as inherited MEN (multiple endocrine neoplasia) syndromes, particularly medullary thyroid cancers where there are confirmed germ-line mutations. Gene rearrangement has been observed in papillary thyroid carcinomas (PTC) and has been shown to have cytoplasmic localization of the altered gene product. C-ret proto-oncogene product is also necessary for the normal development of the peripheral nervous system, enteric nervous system and the kidney. A recent profile of the TK receptors in prostate cancer (PCA) identified c-ret protein in prostate cancer tissue and xenograft derived from human PCA. This study is the first to report the immunohistochemical (IH) evaluation of c-ret in human prostatic tissue.

Thirty radical prostatectomy specimens for PCA were formalin-fixed, sectioned at 5mm and paraffin-embedded.

Type
Neoplasia: Abnormal Cell Growth Or Death/Apoptosis? Insights From Microscopy
Copyright
Copyright © Microscopy Society of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

l.Eng, C.et al., JAMA 276(1996)1575.10.1001/jama.1996.03540190047028CrossRefGoogle Scholar
2.Ishizaka, Y.et al., Oncogene 7(1992)1441.Google ScholarPubMed
3.Tsuzuki, T., Oncogene 10(1995)191.Google ScholarPubMed
4.Robinson, D.et al., Proc. Natl. Acad. Sci 93(1996)5958.10.1073/pnas.93.12.5958CrossRefGoogle Scholar
5.Wood, G.S. and Warnke, R., J of Histochem and Cytochem 29(1981)1196.10.1177/29.10.7028859CrossRefGoogle Scholar
6.Adams, J.C., J of Histochem and Cytochem 29(1981)775.10.1177/29.6.7252134CrossRefGoogle Scholar
7.This study was supported by NIH grants DK51347, CA54031 and CA43703Google Scholar